Literature DB >> 23726881

Transplantation of induced pluripotent stem cells without C-Myc attenuates retinal ischemia and reperfusion injury in rats.

I-Mo Fang1, Chung-May Yang, Chang-Hao Yang, Shih-Hwa Chiou, Muh-Shy Chen.   

Abstract

Induced pluripotent stem cells (iPSC) are novel stem cell populations, but the role of iPSC in retinal ischemia and reperfusion (I/R) injury remains unknown. Since oncogene c-Myc is substantially contributed to tumor formation, in this study, we investigated the effects, mechanisms and safety of subretinal transplantation of iPSC without c-Myc (non-c-Myc iPSC) in a rat model of retinal I/R injury. Retinal I/R injury was induced by raising the intraocular pressure of Sprague-Dawley rats to 110 mmHg for 60 min. A subretinal injection of non-c-Myc iPSC or murine epidermal fibroblast was given 2 h after I/R injury. Electroretinograms (ERG) were performed to determine the functionality of the retinas. The surviving retinal ganglion cells (RGCs) and retinal apoptosis following I/R injury were determined by counting NeuN-positive cells in whole-mounted retinas and TUNEL staining, respectively. The generation of reactive oxygen species (ROS) and the activities of superoxide dismutase (SOD) and catalase (CAT) in the retinal tissues were determined by lucigenin- and luminol-enhanced chemiluminescence and enzyme-linked immunosorbent assay (ELISA). The degree of retinal oxidative damage was assessed by nitrotyrosine, acrolein, and 8-hydroxy-2'-deoxyguanosine (8-OHdG) staining. The expression of brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF) and basic fibroblast growth factor (bFGF) in retinas was measured by immunohistochemistry and ELISA. We found that subretinal transplantation of non-c-Myc iPSC significantly suppressed the I/R-induced reduction in the ERG a- and b-wave ratio, attenuated I/R-induced loss of RGCs and remarkably ameliorated retinal morphological changes. Non-c-Myc iPSC potentially increased the activities of SOD and CAT, decreased the levels of ROS, which may account for preventing retinal cells from apoptotic cell death. In addition, the levels of BDNF and CNTF in retina were significantly elevated in non-c-Myc iPSC-treated eyes. Track the non-c-Myc iPSC after transplantation, most transplanted cells are remained in the subretinal space, with spare cells express neurofilament M markers at day 28. Six months after transplantation in I/R injured rats, no tumor formation was seen in non-c-Myc iPSC graft. In conclusion, non-c-Myc iPSC effectively rescued I/R-induced retinal damages and diminished tumorigenicity. Non-c-Myc iPSC transplantation attenuated retinal I/R injury, possibly via a mechanism involving the regulation of oxidative parameters and paracrinal secretion of trophic factors.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  8-OHdG; 8-hydroxy-2′-deoxyguanosine; BDNF; CAT; CL; CNTF; ERG; ROS; SOD; TUNEL; TdT-dUTP terminal nick-end labeling; bFGF; basic fibroblast growth factor; brain-derived neurotrophic factor; c-Myc; catalase; chemiluminescence; ciliary neurotrophic factor; electroretinogram; iPSC; induced pluripotent stem cells; induced pluropotent stem cells; ischemia-reperfusion injury; oxidative stress; paracrine; reactive oxygen species; superoxide dismutase

Mesh:

Substances:

Year:  2013        PMID: 23726881     DOI: 10.1016/j.exer.2013.05.007

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  17 in total

1.  Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.

Authors:  Kyle D Fink; Andrew T Crane; Xavier Lévêque; Dylan J Dues; Lucas D Huffman; Allison C Moore; Darren T Story; Rachel E Dejonge; Aaron Antcliff; Phillip A Starski; Ming Lu; Laurent Lescaudron; Julien Rossignol; Gary L Dunbar
Journal:  Stem Cells Transl Med       Date:  2014-03-21       Impact factor: 6.940

Review 2.  Current focus of stem cell application in retinal repair.

Authors:  María L Alonso-Alonso; Girish K Srivastava
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

3.  Neuroprotective effects of BDNF and GDNF in intravitreally transplanted mesenchymal stem cells after optic nerve crush in mice.

Authors:  Zong-Li Hu; Ni Li; Xin Wei; Li Tang; Ting-Hua Wang; Xiao-Ming Chen
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

4.  Induced pluripotent stem cells without c-Myc ameliorate retinal oxidative damage via paracrine effects and reduced oxidative stress in rats.

Authors:  I-Mo Fang; Chang-Hao Yang; Shih-Hwa Chiou; Chung-May Yang
Journal:  J Ocul Pharmacol Ther       Date:  2014-08-14       Impact factor: 2.671

5.  Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats.

Authors:  Biji Mathew; Jacqueline N Poston; John C Dreixler; Leianne Torres; Jasmine Lopez; Ruth Zelkha; Irina Balyasnikova; Maciej S Lesniak; Steven Roth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-18       Impact factor: 3.117

6.  Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.

Authors:  Javier A Menendez; Tomás Alarcón; Jorge Joven
Journal:  Cell Cycle       Date:  2014-02-03       Impact factor: 4.534

7.  Sulforaphane protects rodent retinas against ischemia-reperfusion injury through the activation of the Nrf2/HO-1 antioxidant pathway.

Authors:  Hong Pan; Meihua He; Ruixing Liu; Nicholas C Brecha; Albert Cheung Hoi Yu; Mingliang Pu
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

8.  White light-emitting diodes (LEDs) at domestic lighting levels and retinal injury in a rat model.

Authors:  Yu-Man Shang; Gen-Shuh Wang; David Sliney; Chang-Hao Yang; Li-Ling Lee
Journal:  Environ Health Perspect       Date:  2013-12-20       Impact factor: 9.031

Review 9.  Immunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectives.

Authors:  Yuan Tan; Sarah Ooi; Lisheng Wang
Journal:  Curr Stem Cell Res Ther       Date:  2014-01       Impact factor: 3.828

Review 10.  hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.

Authors:  Vikram Sabapathy; Sanjay Kumar
Journal:  J Cell Mol Med       Date:  2016-04-21       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.